<?xml version="1.0" encoding="UTF-8"?>
<p>In this research, all the tested compounds showed a dose-dependent antibacterial in vitro activity against both Cmm and Rs. These evidences corroborated previous results obtained at similar or even lower EOs concentrations against 
 <italic>Pseudomonas syringae</italic> pv. 
 <italic>actinidiae</italic> [
 <xref rid="B37-antibiotics-09-00628" ref-type="bibr">37</xref>]. Regarding Tve, it was previously reported to inhibit mycotoxins production and septoria leaf blotch complex (SLBC) symptoms development without significant effect on fungus growth [
 <xref rid="B39-antibiotics-09-00628" ref-type="bibr">39</xref>,
 <xref rid="B43-antibiotics-09-00628" ref-type="bibr">43</xref>,
 <xref rid="B49-antibiotics-09-00628" ref-type="bibr">49</xref>]. On the contrary, our study highlighted a direct activity in reducing bacterial growth.
</p>
